Global U.S. & Europe Value-Based Healthcare (VBHC) Services Market Size is valued at USD 3.6 Billion in 2024 and is predicted to reach USD 8.1 Billion by the year 2034 at a 8.6% CAGR during the forecast period for 2025-2034.
U.S. & Europe Value-Based Healthcare (VBHC) Services Market refers to a business model in which service providers, including hospitals, are paid according to their patients' effectiveness, efficiency, cost, and health outcomes. Intense supplier competition and growing pressure to lower costs and enhance treatment have shifted from volume-based to value-based healthcare. U.S. & Europe Value-Based Healthcare (VBHC) Services Market benefits everyone more, including patients, providers, payers, suppliers, and society. It focuses on assisting patients in promptly recovering and preventing chronic diseases from improving health at lower costs. High patient satisfaction benefits suppliers in the form of more effective care.
There have been many quick advancements in the healthcare sector since the advent of digital technology, which supports the growth of the market for value-based healthcare services. Due to increased investment by corporate and governmental organizations, there have been several quick improvements in healthcare following the introduction of digital technology. These changes have led to the market for value-based healthcare services expanding.
Furthermore, market participants have more attractive opportunities as chronic diseases like diabetes and cancer become increasingly widespread in developing countries. However, balancing two payment methods and two types of reimbursement is expected to limit the market growth. But it's projected that the lack of Internet access and essential healthcare facilities in some parts of emerging countries will limit the global market for value-based healthcare services throughout the projection period.
· UnitedHealth Group (Optum)
· Humana Inc.
· CVS Health / Aetna
· Elevance Health (Anthem)
· Cigna / Evernorth
· Kaiser Permanente
· Agilon Health
· Aledade
· Lumeris
· Health Catalyst
· Privia Health
· Evolent Health
· Oak Street Health (CVS Health subsidiary)
· VillageMD
· ChenMed
· Signify Health, Inc.
· Stellar Health
· Curation Health (now part of Reveleer)
· Change Healthcare
· NXGN Management, LLC (NextGen Healthcare)
· Athenahealth, Inc.
· McKesson Corporation
· Koninklijke Philips N.V. (Philips Healthcare)
· Siemens Medical Solutions USA, Inc.
· Genpact
· Baker Tilly US, LLP
· Deloitte
· Epic Systems Corporation
· Intermountain Health
· Lumeris
· Veradigm (Allscripts)
· Others
The U.S. & Europe Value-Based Healthcare (VBHC) Services Market is segmented by models, payers category, provider’s utilization category. Based on models, the market is segmented into Pay for performance, Patient-centered medical home, shared savings, shared risk, bundled payment, capitation models. The market is segmented by payers category into Medicare and Medicare advantage, Medicaid, commercial. The market is segmented by provider’s utilization category into home health care, institutional care, self-care, hospital therapy.
This study focuses on the Value-Based Healthcare (VBHC) Services Market across North America and Europe only. These regions were selected based on the maturity of value-based care models, availability of reliable data, and the established presence of major industry participants.
Other geographic regions, including Asia-Pacific, Latin America, and Middle East & Africa, are not covered in this study.
These regions are currently in early or transitional stages of adopting value-based care models, with limited publicly available market and financial data necessary for accurate revenue estimation. Consequently, they fall outside the scope of this analysis.
The patient-centred medical home category dominated the market. Cost transparency is one of the critical developments that will improve the market for value-based healthcare services. By exposing their pricing structure, healthcare systems are assisting patients in better understanding what they are paying for, fostering more patient-health system trust. Patients will grasp the financial implications if they are informed of invoices before they get them. By giving patients clear information about costs, healthcare systems may gain their trust and become more motivated to provide affordable, high-quality care. Through cost transparency, patients can compare options and select the healthcare system that is most appropriate for them. Among the models now on the market, the patient-centred medical home (PCMH) will see a little larger demand.
The North American U.S. & Europe Value-Based Healthcare (VBHC) Services Market is expected to register the highest market share due to increased patient demand for more easily accessible, functional, and affordable care. The established healthcare infrastructure and hub for significant industry players in the region significantly impact the market for value-based healthcare services. Because clinicians understand how early disease identification can lead to high patient satisfaction and enhanced treatment efficiency, value-based healthcare services are commonly used in the United States.
| Report Attribute | Specifications |
| Market Size Value In 2024 | USD 3.6 Billion |
| Revenue Forecast In 2034 | USD 8.1 Billion |
| Growth Rate CAGR | CAGR of 8.6% from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Mn,and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Models, By Service Type, By end user |
| Regional Scope | North America |
| Country Scope | U.S.; Canada; |
| Competitive Landscape | Athena Healthcare, Baker Tilly US, LLP, Boston Consulting Group, Change Healthcare, Curation Health, Deloitte, ForeSee Medical, Inc., Genpact, Humana, Koninklijke Philips N.V., McKesson Corporation, NXGN Management, LLC., Privia Health, Siemens Medical Solutions USA, Inc., Signify Health, Inc. (Sentara Healthcare), Stellar Health, The Commonwealth Fund., UnitedHealth Group., Unlimited Technology Systems, LLC, Veritas Capital Fund Management, L.L.C. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
By Models-
· Shared Savings Model
· Capitation / Global Budget Model
· Bundled Payment Model
· Pay-for-Performance (P4P) Model
· Patient-Centered Medical Home (PCMH)
· Accountable Care Organization (ACO) Model
· Others (Hybrid / Emerging Models)
By Service Type -
· Care Coordination & Management Services
· Population Health Management Services
· Patient Engagement & Experience Services
· Health Data Analytics & Outcome Measurement Services
· Telehealth / Virtual Care Services
· Post-Acute & Home Health Services
· Consulting, Training & Implementation Services
By End-User / Stakeholder
· Hospitals & Health Systems
· Physician Groups / Clinics
· Payers / Insurance Companies
· Government & Public Health Agencies
· Employer-Based Healthcare Programs
· Telehealth & Digital Health Providers
By Region-
North America
· United States
· Canada
Europe
· Germany
· United Kingdom
· France
· Italy
· Spain
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.